
Benjamin A. Schiffman
Examiner (ID: 15490, Phone: (571)270-7626 , Office: P/1742 )
| Most Active Art Unit | 1742 |
| Art Unit(s) | 1791, 4191, 1742 |
| Total Applications | 1223 |
| Issued Applications | 792 |
| Pending Applications | 80 |
| Abandoned Applications | 367 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 16763537
[patent_doc_number] => 20210109118
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-04-15
[patent_title] => ANTIBIOTIC THERAPY GUIDANCE BASED ON PRO-ADM
[patent_app_type] => utility
[patent_app_number] => 16/956046
[patent_app_country] => US
[patent_app_date] => 2018-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23629
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16956046
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/956046 | ANTIBIOTIC THERAPY GUIDANCE BASED ON PRO-ADM | Dec 19, 2018 | Pending |
Array
(
[id] => 16283776
[patent_doc_number] => 20200277378
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-09-03
[patent_title] => COMBINATION THERAPIES
[patent_app_type] => utility
[patent_app_number] => 16/764102
[patent_app_country] => US
[patent_app_date] => 2018-11-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 87544
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -56
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16764102
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/764102 | COMBINATION THERAPIES | Nov 15, 2018 | Abandoned |
Array
(
[id] => 18468866
[patent_doc_number] => 20230203149
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-29
[patent_title] => TREATMENT OF ATOPIC DERMATITIS
[patent_app_type] => utility
[patent_app_number] => 16/647775
[patent_app_country] => US
[patent_app_date] => 2018-09-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15633
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 103
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16647775
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/647775 | TREATMENT OF ATOPIC DERMATITIS | Sep 24, 2018 | Abandoned |
Array
(
[id] => 16156595
[patent_doc_number] => 20200216530
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-07-09
[patent_title] => METHODS AND PHARMACEUTICAL COMPOSITIONS FOR MODULATING MONOCYTOPOIESIS
[patent_app_type] => utility
[patent_app_number] => 16/633900
[patent_app_country] => US
[patent_app_date] => 2018-07-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13614
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16633900
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/633900 | Methods and pharmaceutical compositions for modulating monocytopoiesis | Jul 23, 2018 | Issued |
Array
(
[id] => 15927957
[patent_doc_number] => 20200155612
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-05-21
[patent_title] => HUMAN ORAL MUCOSA STEM CELL SECRETOME
[patent_app_type] => utility
[patent_app_number] => 16/630954
[patent_app_country] => US
[patent_app_date] => 2018-07-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10698
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16630954
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/630954 | HUMAN ORAL MUCOSA STEM CELL SECRETOME | Jul 15, 2018 | Abandoned |
Array
(
[id] => 16466741
[patent_doc_number] => 20200368278
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-11-26
[patent_title] => COMPOSITIONS AND METHODS FOR CELL TARGETING THERAPIES
[patent_app_type] => utility
[patent_app_number] => 16/614691
[patent_app_country] => US
[patent_app_date] => 2018-05-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 46556
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16614691
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/614691 | Compositions and methods for cell targeting therapies | May 17, 2018 | Issued |
Array
(
[id] => 16206555
[patent_doc_number] => 20200239545
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-07-30
[patent_title] => RECEPTOR
[patent_app_type] => utility
[patent_app_number] => 16/486450
[patent_app_country] => US
[patent_app_date] => 2018-02-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12574
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16486450
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/486450 | RECEPTOR | Feb 15, 2018 | Abandoned |
Array
(
[id] => 18345271
[patent_doc_number] => 20230133381
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-04
[patent_title] => ANTI-DR5 ANTIBODY AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/492780
[patent_app_country] => US
[patent_app_date] => 2018-02-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15163
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16492780
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/492780 | Anti-DR5 antibody and use thereof | Feb 7, 2018 | Issued |